Market by Animal Type, Disease Type, Product Type, and Country Outlook | Forecast 2022-2028
Triton Market Research has concluded the veterinary vaccines market in
North America would develop with a CAGR
of 6.91% in the projected period from
2022 to 2028.
Report scope can be customized per your requirements. Request For Customization
The countries analyzed in
this region include:
• The United States
• Canada
An increase in the incidence of animal diseases has led to an enhanced
demand for vaccines across the region. Farm animal owners and pet owners here
opt for effective solutions like vaccination to deal with the diseases that
affect their animals. Increased focus on R&D by market players as well as
other private or government research institutes in the field of animal health
has enhanced the market for veterinary vaccines. Further, a rise in the
awareness and growing acceptance of vaccines to improve animal health and efforts
to tackle diseases by veterinarians are also aiding the market’s growth.
In the United States, diseases, such as bovine viral diarrhea, bovine
tuberculosis, bovine anaplasmosis, etc., are found in cattle stock. Whereas,
diseases such as transmissible gastroenteritis, porcine reproductive &
respiratory syndrome, and others, are found in the swine population. This has
bolstered the demand for veterinary vaccines. The manufacturers and sellers of
these vaccines aid the farm animal producers and veterinarians by offering
solutions to many such diseases.
According to statistics, 41% of Canadian households have at least one
pet dog. The adoption of companion animals in the country is increasing
significantly since the past few years. These animals are at a risk of
developing various diseases, which necessitates the use of veterinary vaccines
for them. Also, the presence of leading market players in the nation presents
an overall positive scope for the studied market’s growth.
Poultry diseases are found in chicken, turkeys, ducks, and other such
birds. As of 2019, the total poultry number of poultry animals globally was
nearly 27.9 billion heads. They are prone to diseases like avian influenza,
avian leukosis virus, Newcastle disease virus, infectious bursal disease virus,
etc. This presents a lucrative growth opportunity to companies manufacturing
poultry animal vaccines.
The studied report assesses the market’s growth
based on animal type, disease type, and product type. Here, the disease type segment comprises
poultry disease, canine disease, porcine disease, aquaculture disease, bovine
disease, and other disease types.
Leading companies considered in the veterinary
vaccines market include Phibro Animal Health, Merck Animal Health, Hipra,
Indian Immunologicals Limited, Hester Biosciences Ltd, and Brilliant Bio
Pharma.
Merck Animal Health is a subsidiary of Merck & Co Inc, a global
leader in the field of healthcare. The company delivers innovative healthcare
solutions through its vaccines, prescription medicines, animal health products,
and biological therapies. The company is engaged in discovering, developing,
manufacturing, and marketing a broad range of veterinary vaccines and
pharmaceuticals, as well as health management solutions and services to
prevent, treat, and control diseases in all major livestock & companion
animal species. The US-based company is headquartered in Kenilworth, New
Jersey.
Key deliverables of the report:
●
Market CAGR during the forecasting years 2022-2028
●
Detailed data highlighting key insights, industry components, and
market strategies
● Comprehensive information and estimation of the veterinary
vaccines market revenue growth in North America and its influence on the parent
market
●
In-depth study of forthcoming trends in consumer behavioral
patterns
●
A meticulous analysis of the competitive landscape, vendor
scorecard, and Porter’s Five Forces
● A wide-ranging study of factors that will challenge the North America
veterinary vaccines market’s growth during the upcoming years
Want to get specific insights? Our team of analysts can customize this
report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA VETERINARY VACCINES MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE VETERINARY VACCINES MARKET
2.2. KEY
INSIGHTS
2.2.1. INCREASING
INNOVATION BY MARKET PARTICIPANTS
2.2.2. ADVANCEMENTS
IN VACCINE AND DIAGNOSTIC TECHNOLOGY
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VALUE
CHAIN ANALYSIS
2.6. KEY
BUYING CRITERIA
2.7. REGULATORY
FRAMEWORK
2.8. VENDOR
SCORECARD
2.9. KEY
MARKET STRATEGIES
2.9.1. MERGERS
& ACQUISITIONS
2.9.2. CONTRACTS
& AGREEMENTS
2.9.3. PRODUCT
LAUNCHES
2.9.4. EXPANSIONS
& DIVESTITURES
2.10. MARKET
DRIVERS
2.10.1. HIGH
VACCINE DEMAND DUE TO INCREASING ANIMAL POPULATION AND DISEASES
2.10.2. GOVERNMENT-ORGANIZED
VACCINATION DRIVES
2.10.3. ADVANCED
VACCINE RESEARCH AND DEVELOPMENT
2.11. MARKET
CHALLENGES
2.11.1. LACK
OF AWARENESS AND SCARCITY OF SKILLED VETERINARIANS
2.11.2. STRINGENT
RULES AND REGULATIONS PERTAINING TO VACCINE USE
2.12. MARKET
OPPORTUNITIES
2.12.1. GROWING
USE OF VACCINES IN THE AMERICAN MARKET
2.12.2. RISING
DEMAND FOR COMPANION ANIMALS
3. NORTH
AMERICA VETERINARY VACCINES MARKET OUTLOOK – BY ANIMAL TYPE
3.1. LIVESTOCK
ANIMALS
3.1.1. CATTLE
3.1.2. PIGS
3.1.3. POULTRY
3.1.4. SHEEP
3.1.5. OTHER
LIVESTOCK ANIMALS
3.2. COMPANION
ANIMALS
3.2.1. CANINE
3.2.2. FELINE
3.2.3. EQUINE
3.3. AQUACULTURE
4. NORTH
AMERICA VETERINARY VACCINES MARKET OUTLOOK – BY DISEASE TYPE
4.1. CANINE
DISEASE
4.2. PORCINE
DISEASE
4.3. BOVINE
DISEASE
4.4. POULTRY
DISEASE
4.5. AQUACULTURE
DISEASE
4.6. OTHER
DISEASE TYPES
5. NORTH
AMERICA VETERINARY VACCINES MARKET OUTLOOK – BY PRODUCT TYPE
5.1. ATTENUATED
VACCINES
5.2. INACTIVATED
VACCINES
5.3. TOXOID
VACCINES
5.4. CONJUGATE
VACCINES
5.5. DNA
VACCINES
5.6. RECOMBINANT
VACCINES
5.7. SUBUNIT
VACCINES
6. NORTH
AMERICA VETERINARY VACCINES MARKET – COUNTRY OUTLOOK
6.1. UNITED
STATES
6.2. CANADA
7. COMPETITIVE
LANDSCAPE
7.1. BOEHRINGER
INGELHEIM INTERNATIONAL GMBH
7.2. BRILLIANT
BIO PHARMA
7.3. CEVA
SANTE ANIMALE
7.4. ELANCO
ANIMAL HEALTH INC
7.5. HESTER
BIOSCIENCES LTD
7.6. HIPRA
7.7. INDIAN
IMMUNOLOGICALS LIMITED
7.8. MERCK
ANIMAL HEALTH
7.9. PHIBRO
ANIMAL HEALTH
7.10. VAXXINOVA
GMBH
7.11. VIRBAC
SA
7.12. ZOETIS
INC
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: NORTH AMERICA
VETERINARY VACCINES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: VENDOR SCORECARD
TABLE 4: NORTH AMERICA
VETERINARY VACCINES MARKET, BY ANIMAL TYPE, 2022-2028 (IN $ MILLION)
TABLE 5: NORTH AMERICA
VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA VETERINARY
VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028 (IN $ MILLION)
TABLE 7: NORTH AMERICA
VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA
VETERINARY VACCINES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA
VETERINARY VACCINES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
FIGURE
1: MARKET ATTRACTIVENESS INDEX
FIGURE
2: VALUE CHAIN ANALYSIS
FIGURE
3: KEY BUYING CRITERIA
FIGURE
4: NORTH AMERICA VETERINARY VACCINES MARKET, BY ANIMAL TYPE, 2021 & 2028
(IN %)
FIGURE
5: NORTH AMERICA VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028
(IN $ MILLION)
FIGURE
6: NORTH AMERICA VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2021 &
2028 (IN %)
FIGURE
7: NORTH AMERICA VETERINARY VACCINES MARKET, BY CATTLE, 2022-2028 (IN $
MILLION)
FIGURE
8: NORTH AMERICA VETERINARY VACCINES MARKET, BY PIGS, 2022-2028 (IN $ MILLION)
FIGURE
9: NORTH AMERICA VETERINARY VACCINES MARKET, BY POULTRY, 2022-2028 (IN $
MILLION)
FIGURE
10: NORTH AMERICA VETERINARY VACCINES MARKET, BY SHEEP, 2022-2028 (IN $
MILLION)
FIGURE
11: NORTH AMERICA VETERINARY VACCINES MARKET, BY OTHER LIVESTOCK ANIMALS,
2022-2028 (IN $ MILLION)
FIGURE
12: NORTH AMERICA VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028
(IN $ MILLION)
FIGURE
13: NORTH AMERICA VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2021 &
2028 (IN %)
FIGURE
14: NORTH AMERICA VETERINARY VACCINES MARKET, BY CANINE, 2022-2028 (IN $
MILLION)
FIGURE
15: NORTH AMERICA VETERINARY VACCINES MARKET, BY FELINE, 2022-2028 (IN $
MILLION)
FIGURE
16: NORTH AMERICA VETERINARY VACCINES MARKET, BY EQUINE, 2022-2028 (IN $
MILLION)
FIGURE
17: NORTH AMERICA VETERINARY VACCINES MARKET, BY AQUACULTURE, 2022-2028 (IN $
MILLION)
FIGURE
18: NORTH AMERICA VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2021 & 2028
(IN %)
FIGURE
19: NORTH AMERICA VETERINARY VACCINES MARKET, BY CANINE DISEASE, 2022-2028 (IN
$ MILLION)
FIGURE
20: NORTH AMERICA VETERINARY VACCINES MARKET, BY PORCINE DISEASE, 2022-2028 (IN
$ MILLION)
FIGURE
21: NORTH AMERICA VETERINARY VACCINES MARKET, BY BOVINE DISEASE, 2022-2028 (IN
$ MILLION)
FIGURE
22: NORTH AMERICA VETERINARY VACCINES MARKET, BY POULTRY DISEASE, 2022-2028 (IN
$ MILLION)
FIGURE
23: NORTH AMERICA VETERINARY VACCINES MARKET, BY AQUACULTURE DISEASE, 2022-2028
(IN $ MILLION)
FIGURE
24: NORTH AMERICA VETERINARY VACCINES MARKET, BY OTHER DISEASE TYPE, 2022-2028
(IN $ MILLION)
FIGURE
25: NORTH AMERICA VETERINARY VACCINES MARKET, BY PRODUCT TYPE, 2021 & 2028
(IN %)
FIGURE
26: NORTH AMERICA VETERINARY VACCINES MARKET, BY ATTENUATED VACCINES, 2022-2028
(IN $ MILLION)
FIGURE
27: NORTH AMERICA VETERINARY VACCINES MARKET, BY INACTIVATED VACCINES,
2022-2028 (IN $ MILLION)
FIGURE
28: NORTH AMERICA VETERINARY VACCINES MARKET, BY TOXOID VACCINES, 2022-2028 (IN
$ MILLION)
FIGURE
29: NORTH AMERICA VETERINARY VACCINES MARKET, BY CONJUGATE VACCINES, 2022-2028
(IN $ MILLION)
FIGURE
30: NORTH AMERICA VETERINARY VACCINES MARKET, BY DNA VACCINES, 2022-2028 (IN $
MILLION)
FIGURE
31: NORTH AMERICA VETERINARY VACCINES MARKET, BY RECOMBINANT VACCINES,
2022-2028 (IN $ MILLION)
FIGURE
32: NORTH AMERICA VETERINARY VACCINES MARKET, BY SUBUNIT VACCINES, 2022-2028
(IN $ MILLION)
FIGURE
33: NORTH AMERICA VETERINARY VACCINES MARKET, COUNTRY OUTLOOK, 2021 & 2028
(IN %)
FIGURE
34: UNITED STATES VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE
35: CANADA VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)